Neuroprotection of Fasting Mimicking Diet on MPTP-Induced Parkinson’s Disease Mice via Gut Microbiota and Metabolites
暂无分享,去创建一个
Chun Cui | Chenmeng Qiao | Li-Ping Zhao | Yan-Qin Shen | Zhilan Zhou | Mengfei Sun | Ying-li Zhu | Xuebing Jia | Chen-Meng Qiao | Xue Chen | Qin Yang | Boping Zhang | Liping Zhao
[1] M. Mccarty,et al. Nutraceuticals Targeting Generation and Oxidant Activity of Peroxynitrite May Aid Prevention and Control of Parkinson’s Disease , 2020, International journal of molecular sciences.
[2] M. Contarino,et al. Fecal Microbiota Transplantation in Neurological Disorders , 2020, Frontiers in Cellular and Infection Microbiology.
[3] L. Vitetta,et al. The Role of Butyrate in Attenuating Pathobiont-Induced Hyperinflammation , 2020, Immune network.
[4] E. Quigley,et al. Recent advances in modulating the microbiome , 2020, F1000Research.
[5] A. Keshavarzian,et al. Diet in Parkinson's Disease: Critical Role for the Microbiome , 2019, Front. Neurol..
[6] Yong Tang,et al. Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson’s Disease , 2018, Neurochemical Research.
[7] R. Duvoisin,et al. Effects of Sub-Chronic MPTP Exposure on Behavioral and Cognitive Performance and the Microbiome of Wild-Type and mGlu8 Knockout Female and Male Mice , 2018, Front. Behav. Neurosci..
[8] Chun Cui,et al. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson’s disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway , 2018, Brain, Behavior, and Immunity.
[9] Chunyan Wu,et al. Alteration of the fecal microbiota in Chinese patients with Parkinson’s disease , 2018, Brain, Behavior, and Immunity.
[10] Fangming Li,et al. Vitexin protects dopaminergic neurons in MPTP-induced Parkinson’s disease through PI3K/Akt signaling pathway , 2018, Drug design, development and therapy.
[11] Chenhong Zhang,et al. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes , 2018, Science.
[12] Q. Xiao,et al. Longitudinal Analysis of Fecal Microbiome and Pathologic Processes in a Rotenone Induced Mice Model of Parkinson’s Disease , 2018, Front. Aging Neurosci..
[13] Daxesh P. Patel,et al. Intermittent Fasting Promotes White Adipose Browning and Decreases Obesity by Shaping the Gut Microbiota. , 2017, Cell metabolism.
[14] S. Prakash,et al. Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis , 2017, Cellular and Molecular Life Sciences.
[15] Hailian Shi,et al. Amentoflavone protects dopaminergic neurons in MPTP‐induced Parkinson's disease model mice through PI3K/Akt and ERK signaling pathways , 2017, Toxicology and applied pharmacology.
[16] Ramón Cacabelos,et al. Parkinson’s Disease: From Pathogenesis to Pharmacogenomics , 2017, International journal of molecular sciences.
[17] S. Groshen,et al. Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease , 2017, Science Translational Medicine.
[18] N. Hattori,et al. Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke , 2017, PloS one.
[19] Julie B. Sneddon,et al. Fasting-Mimicking Diet Promotes Ngn3-Driven β-Cell Regeneration to Reverse Diabetes , 2017, Cell.
[20] G. Niewiadomska,et al. The role of trophic factors and inflammatory processes in physical activity-induced neuroprotection in Parkinson's disease. , 2017, Postepy higieny i medycyny doswiadczalnej.
[21] J. Volkmann,et al. Parkinson disease , 2017, Nature Reviews Disease Primers.
[22] Rob Knight,et al. Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease , 2016, Cell.
[23] K. Fassbender,et al. Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls. , 2016, Parkinsonism & related disorders.
[24] Shyamal K. Das,et al. Gut dysfunction in Parkinson's disease. , 2016, World journal of gastroenterology.
[25] T. Morgan,et al. A Diet Mimicking Fasting Promotes Regeneration and Reduces Autoimmunity and Multiple Sclerosis Symptoms. , 2016, Cell reports.
[26] W. Boon,et al. Fatty acids and their therapeutic potential in neurological disorders , 2016, Neurochemistry International.
[27] S. Davies,et al. Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions , 2016, Genome Medicine.
[28] J. Clemente,et al. Microbiota-driven transcriptional changes in prefrontal cortex override genetic differences in social behavior , 2016, eLife.
[29] T. Dinan,et al. Growing up in a Bubble: Using Germ-Free Animals to Assess the Influence of the Gut Microbiota on Brain and Behavior , 2016, The international journal of neuropsychopharmacology.
[30] P. Bertrand,et al. Influence of Tryptophan and Serotonin on Mood and Cognition with a Possible Role of the Gut-Brain Axis , 2016, Nutrients.
[31] T. van der Poll,et al. The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia , 2015, Gut.
[32] Ali Keshavarzian,et al. Colonic bacterial composition in Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.
[33] S. Groshen,et al. A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and Healthspan. , 2015, Cell metabolism.
[34] E. Pekkonen,et al. Gut microbiota are related to Parkinson's disease and clinical phenotype , 2015, Movement disorders : official journal of the Movement Disorder Society.
[35] T. Huan,et al. Development of high-performance chemical isotope labeling LC-MS for profiling the human fecal metabolome. , 2015, Analytical chemistry.
[36] T. Dinan,et al. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis , 2015, Behavioural Brain Research.
[37] S. Shioda,et al. A Nucleoprotein-Enriched Diet Suppresses Dopaminergic Neuronal Cell Loss and Motor Deficit in Mice with MPTP-Induced Parkinson’s Disease , 2015, Journal of Molecular Neuroscience.
[38] S. Yooseph,et al. Diet and feeding pattern affect the diurnal dynamics of the gut microbiome. , 2014, Cell metabolism.
[39] A. Ghanem,et al. Enantioselective nano liquid chromatographic separation of racemic pharmaceuticals: a facile one-pot in situ preparation of lipase-based polymer monoliths in capillary format. , 2014, Chirality.
[40] Matthew L. Jenior,et al. Intra- and Interindividual Variations Mask Interspecies Variation in the Microbiota of Sympatric Peromyscus Populations , 2014, Applied and Environmental Microbiology.
[41] M. Mattson,et al. Intermittent fasting attenuates lipopolysaccharide-induced neuroinflammation and memory impairment , 2014, Journal of Neuroinflammation.
[42] J. Yates,et al. Microglia Promote Learning-Dependent Synapse Formation through Brain-Derived Neurotrophic Factor , 2013, Cell.
[43] P. Scully,et al. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner , 2013, Molecular Psychiatry.
[44] S. Tringe,et al. Diversity and heritability of the maize rhizosphere microbiome under field conditions , 2013, Proceedings of the National Academy of Sciences.
[45] Nora C. Toussaint,et al. Intestinal Microbiota Containing Barnesiella Species Cures Vancomycin-Resistant Enterococcus faecium Colonization , 2013, Infection and Immunity.
[46] M. Garcia-Conesa,et al. Alternative method for gas chromatography-mass spectrometry analysis of short-chain fatty acids in faecal samples. , 2012, Journal of separation science.
[47] F. Cicchetti,et al. High-fat diet exacerbates MPTP-induced dopaminergic degeneration in mice , 2012, Neurobiology of Disease.
[48] F. Cicchetti,et al. The critical role of the MyD88-dependent pathway in non-CNS MPTP-mediated toxicity , 2011, Brain, Behavior, and Immunity.
[49] Baoji Xu,et al. Chronic deprivation of TrkB signaling leads to selective late-onset nigrostriatal dopaminergic degeneration , 2011, Experimental Neurology.
[50] F. Fornai,et al. MPTP-induced parkinsonism extends to a subclass of TH-positive neurons in the gut , 2010, Brain Research.
[51] Robert C. Edgar,et al. BIOINFORMATICS APPLICATIONS NOTE , 2001 .
[52] William A. Walters,et al. QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.
[53] Jeffrey N. Weiser,et al. Recognition of Peptidoglycan from the Microbiota by Nod1 Enhances Systemic Innate Immunity , 2010, Nature Medicine.
[54] Naoki Takemura,et al. Response of Gut Microbiota to Fasting and Hibernation in Syrian Hamsters , 2009, Applied and Environmental Microbiology.
[55] Gabriel Núñez,et al. The innate immune receptor Nod1 protects the intestine from inflammation-induced tumorigenesis. , 2008, Cancer research.
[56] M. Bergami,et al. Uptake and recycling of pro-BDNF for transmitter-induced secretion by cortical astrocytes , 2008, The Journal of cell biology.
[57] R. Balázs,et al. Interleukin-1β impairs brain derived neurotrophic factor-induced signal transduction , 2008, Neurobiology of Aging.
[58] T. Powley,et al. Alpha-synuclein-immunopositive myenteric neurons and vagal preganglionic terminals: Autonomic pathway implicated in Parkinson's disease? , 2008, Neuroscience.
[59] S. Srinivasan,et al. Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease , 2007, Experimental Neurology.
[60] J. Tiedje,et al. Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy , 2007, Applied and Environmental Microbiology.
[61] H. Braak,et al. Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology , 2006, Neuroscience Letters.
[62] Eoin L. Brodie,et al. Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARB , 2006, Applied and Environmental Microbiology.
[63] Houeto Jean-Luc. [Parkinson's disease]. , 2022, La Revue du praticien.
[64] C. Gravel,et al. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain , 2005, Nature.
[65] Ji-Young Choi,et al. Enhanced susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in high-fat diet-induced obesity. , 2005, Free radical biology & medicine.
[66] Richard E. Carson,et al. Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[67] J. W. Rudy,et al. BDNF mRNA expression in rat hippocampus following contextual learning is blocked by intrahippocampal IL-1β administration , 2004, Journal of Neuroimmunology.
[68] J. Gorski,et al. Early Striatal Dendrite Deficits followed by Neuron Loss with Advanced Age in the Absence of Anterograde Cortical Brain-Derived Neurotrophic Factor , 2004, The Journal of Neuroscience.
[69] M. Mattson,et al. Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[70] A. Kingsbury,et al. Elevated glial brain-derived neurotrophic factor in Parkinson's diseased nigra. , 2002, Parkinsonism & related disorders.
[71] M. Mattson,et al. Brain‐derived neurotrophic factor mediates an excitoprotective effect of dietary restriction in mice , 2001, Journal of neurochemistry.
[72] G. Donnan,et al. Reduced BDNF mRNA Expression in the Parkinson's Disease Substantia Nigra , 2000, Experimental Neurology.
[73] S. Furukawa,et al. Lipopolysaccharide enhances synthesis of brain‐derived neurotrophic factor in cultured rat microglia , 1997, Journal of neuroscience research.
[74] I. Black,et al. Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[75] R. Berg,et al. Effect of starvation, malnutrition, and trauma on the gastrointestinal tract flora and bacterial translocation. , 1987, Archives of surgery.
[76] J. Langston,et al. Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A neurochemical and morphological reassessment , 1986, Brain Research.